Applied Therapeutics, Inc. Net Income
Applied Therapeutics, Inc. reported Net Income of -$18.99 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2025-11-13
- Applied Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$18.99M.
- Applied Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2025-06-30 was -$21.33M, a 836.02% decline year-over-year.
- Applied Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2025-03-31 was -$21.82M.
- Applied Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2024-12-31 was $44.01M.
- Applied Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2024 was -$105.62M.
- Applied Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2023 was -$119.76M.
- Applied Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2022 was -$82.51M.
- Applied Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2021 was -$105.58M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$18.99M 10-Q · filed 2025-11-13 | -$40.32M derived: sum of 2 quarters · filed 2025-11-13 | -$62.15M 10-Q · filed 2025-11-13 | -$18.14M derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | -$21.33M 10-Q · filed 2025-11-13 | -$43.16M 10-Q · filed 2025-08-13 | $852.00K derived: sum of 3 quarters · filed 2025-11-13 | -$67.74M derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-03-31 | -$21.82M 10-Q · filed 2025-11-13 | $22.18M derived: sum of 2 quarters · filed 2025-11-13 | -$46.41M derived: sum of 3 quarters · filed 2025-11-13 | -$43.51M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-12-31 | $44.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$24.58M derived: sum of 2 quarters · filed 2025-11-13 | -$21.69M derived: sum of 3 quarters · filed 2025-11-13 | -$105.62M 10-K · filed 2025-04-15 |
| 2024-09-30 | -$68.59M 10-Q · filed 2025-11-13 | -$65.69M derived: sum of 2 quarters · filed 2025-11-13 | -$149.63M 10-Q · filed 2025-11-13 | -$187.31M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $2.90M 10-Q · filed 2025-11-13 | -$81.04M 10-Q · filed 2025-08-13 | -$118.72M derived: sum of 3 quarters · filed 2025-11-13 | -$161.09M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-03-31 | -$83.94M 10-Q · filed 2025-11-13 | -$121.62M derived: sum of 2 quarters · filed 2025-11-13 | -$163.99M derived: sum of 3 quarters · filed 2025-11-13 | -$193.56M derived: sum of 4 quarters · filed 2025-11-13 |
| 2023-12-31 | -$37.68M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$80.05M derived: sum of 2 quarters · filed 2025-04-15 | -$109.63M derived: sum of 3 quarters · filed 2025-04-15 | -$119.76M 10-K · filed 2025-04-15 |
| 2023-09-30 | -$42.37M 10-Q · filed 2024-11-07 | -$71.95M derived: sum of 2 quarters · filed 2024-11-07 | -$82.08M 10-Q · filed 2024-11-07 | -$96.51M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$29.58M 10-Q · filed 2024-11-07 | -$39.71M 10-Q · filed 2024-08-07 | -$54.14M derived: sum of 3 quarters · filed 2024-11-07 | -$73.24M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-03-31 | -$10.14M 10-Q · filed 2024-11-07 | -$24.57M derived: sum of 2 quarters · filed 2024-11-07 | -$43.67M derived: sum of 3 quarters · filed 2024-11-07 | -$69.52M derived: sum of 4 quarters · filed 2024-11-07 |
| 2022-12-31 | -$14.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | -$33.53M derived: sum of 2 quarters · filed 2024-03-06 | -$59.39M derived: sum of 3 quarters · filed 2024-03-06 | -$82.51M 10-K · filed 2024-03-06 |
| 2022-09-30 | -$19.10M 10-Q · filed 2023-11-09 | -$44.96M derived: sum of 2 quarters · filed 2023-11-09 | -$68.08M 10-Q · filed 2023-11-09 | -$95.24M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$25.86M 10-Q · filed 2023-11-09 | -$48.98M 10-Q · filed 2023-08-10 | -$76.14M derived: sum of 3 quarters · filed 2023-11-09 | -$104.56M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-03-31 | -$23.12M 10-Q · filed 2023-11-09 | -$50.28M derived: sum of 2 quarters · filed 2023-11-09 | -$78.70M derived: sum of 3 quarters · filed 2023-11-09 | -$104.53M derived: sum of 4 quarters · filed 2023-11-09 |
| 2021-12-31 | -$27.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$55.58M derived: sum of 2 quarters · filed 2023-03-23 | -$81.41M derived: sum of 3 quarters · filed 2023-03-23 | -$105.58M 10-K · filed 2023-03-23 |
| 2021-09-30 | -$28.42M 10-Q · filed 2022-11-09 | -$54.25M derived: sum of 2 quarters · filed 2022-11-09 | -$78.42M 10-Q · filed 2022-11-09 | -$102.11M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$25.83M 10-Q · filed 2022-11-09 | -$50.01M 10-Q · filed 2022-08-12 | -$73.70M derived: sum of 3 quarters · filed 2022-11-09 | -$103.54M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-03-31 | -$24.18M 10-Q · filed 2022-11-09 | -$47.87M derived: sum of 2 quarters · filed 2022-11-09 | -$77.71M derived: sum of 3 quarters · filed 2022-11-09 | -$105.77M derived: sum of 4 quarters · filed 2022-11-09 |
| 2020-12-31 | -$23.69M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$53.53M derived: sum of 2 quarters · filed 2022-03-10 | -$81.59M derived: sum of 3 quarters · filed 2022-03-10 | -$93.96M 10-K · filed 2022-03-10 |
| 2020-09-30 | -$29.84M 10-Q · filed 2021-11-12 | -$57.90M derived: sum of 2 quarters · filed 2021-11-12 | -$70.27M 10-Q · filed 2021-11-12 | -$87.91M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | -$28.06M 10-Q · filed 2021-11-12 | -$40.43M 10-Q · filed 2021-08-12 | -$58.06M derived: sum of 3 quarters · filed 2021-11-12 | -$68.77M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-03-31 | -$12.37M 10-Q · filed 2021-11-12 | -$30.00M derived: sum of 2 quarters · filed 2021-11-12 | -$40.72M derived: sum of 3 quarters · filed 2021-11-12 | -$49.15M derived: sum of 4 quarters · filed 2021-11-12 |
| 2019-12-31 | -$17.63M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$28.35M derived: sum of 2 quarters · filed 2021-03-18 | -$36.78M derived: sum of 3 quarters · filed 2021-03-18 | -$45.51M 10-K · filed 2021-03-18 |
| 2019-09-30 | -$10.71M 10-Q · filed 2020-11-12 | -$19.15M derived: sum of 2 quarters · filed 2020-11-12 | -$27.88M 10-Q · filed 2020-11-12 | -$34.60M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$8.44M 10-Q · filed 2020-11-12 | -$17.17M 10-Q · filed 2020-08-11 | -$23.89M derived: sum of 3 quarters · filed 2020-11-12 | -$28.17M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-03-31 | -$8.73M 10-Q · filed 2020-11-12 | -$15.45M derived: sum of 2 quarters · filed 2020-11-12 | -$19.73M derived: sum of 3 quarters · filed 2020-11-12 | -$22.91M derived: sum of 4 quarters · filed 2020-11-12 |
| 2018-12-31 | -$6.72M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$11.00M derived: sum of 2 quarters · filed 2020-03-13 | -$14.19M derived: sum of 3 quarters · filed 2020-03-13 | -$16.52M 10-K · filed 2020-03-13 |
| 2018-09-30 | -$4.28M 10-Q · filed 2019-11-13 | -$7.47M derived: sum of 2 quarters · filed 2019-11-13 | -$9.80M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | -$3.19M 10-Q · filed 2019-11-13 | -$5.52M 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | -$2.33M 10-Q · filed 2019-11-13 |